138 related articles for article (PubMed ID: 7308253)
21. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
Moroson H; Rotman M; Schechter M
Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
[No Abstract] [Full Text] [Related]
22. [Immunotherapy of lung cancer].
Jassem J; Jassem E
Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
[No Abstract] [Full Text] [Related]
23. Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.
Sparks FC; O'Connell TX; Lee YT
Surg Forum; 1973; 24():118-21. PubMed ID: 4618633
[No Abstract] [Full Text] [Related]
24. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
Moroson H; Stowe S; Rotman M; Schechter M
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
[No Abstract] [Full Text] [Related]
25. [Corynebacteria--stimulators of antitumor resistance].
Zatula DG; Zaval'niuk AK; Tofan AV
Eksp Onkol; 1984; 6(6):12-8. PubMed ID: 6396064
[TBL] [Abstract][Full Text] [Related]
26. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
Bartlett GL; Kreider JW; Purnell DM
Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
[TBL] [Abstract][Full Text] [Related]
27. Relationship between intradermal tumor suppression and tumor immunity.
Bartlett GL; Kreider JW; Purnell DM
J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
[TBL] [Abstract][Full Text] [Related]
28. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests.
Palladino MA; Thorbecke GJ
Cell Immunol; 1978 Jul; 38(2):336-49. PubMed ID: 354799
[No Abstract] [Full Text] [Related]
29. Effect of immunostimulating agents on viral infections.
Zerial A; Werner GH
Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
[No Abstract] [Full Text] [Related]
30. Intratumoral BCG and Corynebacterium parvum therapy of canine mammary tumours before radical mastectomy.
Parodi AL; Misdorp W; Mialot JP; Mialot M; Hart AA; Hurtrel M; Salomon JC
Cancer Immunol Immunother; 1983; 15(3):172-7. PubMed ID: 6555059
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy of human cancer.
Hersh EM; Gutterman JU; Mavligit GM
Adv Intern Med; 1977; 22():145-85. PubMed ID: 65906
[No Abstract] [Full Text] [Related]
32. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW; Biro TG
Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
[TBL] [Abstract][Full Text] [Related]
33. Active immunization of rats against two tumoral ascites using live cells associated with Corynebacterium parvum.
Lupu A
Arch Roum Pathol Exp Microbiol; 1987; 46(2):167-71. PubMed ID: 3455654
[No Abstract] [Full Text] [Related]
34. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
35. [Current trends in immunotherapy of tumors of the lung].
Crispano G; Toglia V; Tranchese D; Schettini R
Arch Monaldi; 1983; 38(1-2):41-52. PubMed ID: 6675558
[No Abstract] [Full Text] [Related]
36. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
Thomson AW; Cruickshank N; Fowler EF
Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
[No Abstract] [Full Text] [Related]
37. Development of a bioassay for anti tumor activity of biological response modifiers of the reticuloendothelial stimulant class: reproducibility of the bioassay.
Proctor JW; Yamamura Y; DiLuzio NR; Mansell PW
J Immunopharmacol; 1981-1982; 3(3-4):385-95. PubMed ID: 6752286
[TBL] [Abstract][Full Text] [Related]
38. Effect of vaccination and the immunomodulators "bacillus of Calmette-Guérin, avridine and Propionibacterium acnes" on rabies in mice.
Megid J; Peraçolli MT; Curi PR; Zanetti CR; Cabrera WH; Vassao R; Ito FH
Comp Immunol Microbiol Infect Dis; 1998 Oct; 21(4):305-18. PubMed ID: 9775360
[TBL] [Abstract][Full Text] [Related]
39. Tumour models for screening immunomodulators: suppression of tumour growth by delayed hypersensitivity reactions.
Pimm MV; Baldwin RW
Behring Inst Mitt; 1984 May; (74):214-8. PubMed ID: 6383324
[TBL] [Abstract][Full Text] [Related]
40. [Immunotherapy of breast cancer (review of foreign literature)].
Liapis MA
Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
